UBS Group AG - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q4 2022$3,936
+96.8%
400
+101.0%
0.00%
Q2 2022$2,000
-75.0%
199
-75.1%
0.00%
Q1 2022$8,000
+300.0%
799
+301.5%
0.00%
Q4 2021$2,000
-85.7%
199
-85.9%
0.00%
Q3 2021$14,0000.0%1,408
+2.2%
0.00%
Q2 2021$14,000
-48.1%
1,378
-48.5%
0.00%
Q1 2021$27,000
+42.1%
2,678
+53.2%
0.00%
Q4 2020$19,0001,7480.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2020
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,264,0001.59%
Endurant Capital Management LP 195,000$2,079,0000.75%
CVI Holdings, LLC 355,000$3,784,0000.71%
Wealthspring Capital LLC 129,880$1,385,0000.69%
Sio Capital Management, LLC 300,000$3,198,0000.66%
Monashee Investment Management LLC 300,000$3,198,0000.42%
Sage Mountain Advisors LLC 95,970$1,023,0000.34%
683 Capital Management, LLC 600,000$6,396,0000.30%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 200,000$2,138,0000.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,132,0000.23%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders